Chapter - 4 A GENERALISED PREY-PREDATOR MODEL OF CANCER GROWTH WITH THE EFFECT OF IMMUNOTHERAPY INTRODUCTION Cancer is one of the greatest killers in many countries and the control of cancer growth requires special attention. In the present chapter, we study a generalized mathematical model on cancer growth and its treatment by immunotherapy as a deterministic prey-predator like model. We assume that the prey is cancer cells and predators are immune cells. Two types of Immune cells are considered namely resting cells or T-helper cells and hunting cells or cytotoxic Tlymphocytes. When T-helper cells find malignant cancer cells, they release a series of stimulating agents (cytokines, IL-2, interferon gamma etc.) that activate the hunting cells to kill cancer cells. The process of natural immune attack against cancer cells is not always sustainable and therefore several techniques and methodologies have been developed to enhance natural immune response against cancer. This method of treatment of cancer is called immunotherapy. In this therapy, blood is drawn from cancer patients and then immune cells are expanded in number artificially which are again put back into the bloodstream. In this chapter, we modify the model given by Nani and Freedman (2000) by considering induction of primary immune response against cancer in resting cells or T- helper cells as a function of cancer cells in the body. The model is analyzed for stability of equilibria using stability theory of differential equations. Moreover, the 68 numerical simulation of the proposed model is also performed by using fourth order Runge - Kutta method. 4.1 MATHEMATICAL MODEL Mathematical modeling of the actual phenomenon in the cancer immune cell interactions is very difficult. We present here a very basic and general mathematical model to discuss the interaction among cancer and immune cells of the body. We study a three dimensional model with cancer cells x(t ) , hunting cells y (t ) and resting cells z (t ) using a system of nonlinear ordinary differential equations. Each equation of the system represents the rate of change of a variable with respect to time. Thus, the final form of mathematical model is, dx B( x) D( x) h( x, y ), dt dy Q1 f ( y, z ) 1d1 ( y ) h( x, y ), dt (4.1.1) dz Q2 ( x) f ( y, z ) 2 d 2 ( z ), dt with, x(t 0 ) x0 0, y(t0 ) y0 0, z (t0 ) z0 0. We assume that the cancer cells are proliferating at the rate B (x ) defined as the birth rate and dying at the rate D(x) . Q1 and Q2 are the proliferation rate of hunting and resting cells respectively due to external infusion of immune cells during immunotherapy. 1 , 2 , and are the positive constants. In addition, our model is based on following hypothesis given below: 69 H1: There do not exist negative solutions x(t ) , y (t ) and z (t ) for non-small t, since they are physically unacceptable, so that x(t ) 0 y (t ) 0 and z (t ) 0 t 0. H2:The term f ( y , z ) represents the rate of proliferation of hunting cells due to release of series of stimulating agents from by resting cells. It is characterized by f y ( y, z ) 0, y 0, z 0, f z ( y, z) 0, y 0, z 0, f (0, z ) 0, f ( y,0) 0 H3: h( x, y ) represents the cancer cell destruction by hunting cells due to stimulation by resting cells. It may be assumed that hx ( x, y) 0, x 0, y 0, h y ( x, y ) 0, x 0, y 0, h y (0, y) 0, y 0 hx (0, y) 0, y 0, h(0, y ) 0, h( x,0) 0 . H4: d1 ( y) and d 2 ( z ) represent the elimination of hunting and resting cells respectively. It satisfies following conditions: d1, 2 (0) 0, d1 (0) 0, y 0, d 2 (0) 0, z 0 H5: (x) is the induction of primary immune response against cancer in resting cells that is assumed to be a function of cancer cells population in the body. It satisfies following conditions: (0) 0, ( x) 0, x 0, ( x) 0, x 0. H6: The birth and death rates of cancer cells are based on following assumptions: B(0) D(0), B( x) 0, D( x) 0, B (0) 0, D(0) 0, and there exist a value K 0 such that B( K ) D( K ) and B ( K ) D( K ). Note: Here f y , f z , hx , hy represent partial derivatives of functions f ( y, z ) and h( x, y ) with respect to the variables y , z , x respectively. B( x), D( x) and (x ) are the total derivatives of B( x), D( x) and (x) with respect to x respectively. 70 4.2 BOUNDEDNESS Here we show that system (4.1.1) is bounded. Theorem 4.1: All solutions of system (4.1.1) with initial values in R3 are bounded in Q1 3 ( x, y, z ) R ,0 x(t ) K ,0 y (t ) ,1 0, 1 the region defined by 0 z (t ) Q2 ( K ) , 0 2 2 . Where, ~ ~ 1 max max f ( y, z ) 1 min d1 ( y) , y y, z y, z ~ 2 2 min d 2 ( z) 0 . z Proof: Let x0 0 , considering first equation of model (4.1.1) we have dx B( x) D( x) h( x, y ), dt dx B( x) D( x). dt But by hypothesis there exist a value K 0 such that B( K ) D( K ) . Thus, x(t ) max( K , x0 ) We note that dx 0 for x K and hence, dt lim sup x(t ) K . t Let us now consider second equation of system (4.1.1), dy Q1 f ( y, z ) 1d1 ( y ) h( x, y ), dt 71 dy Q1 f ( y, z ) 1d1 ( y ), dt ~ ~ Q1 y max f ( y, z ) y1 min d1 ( y), y y, z ~ ~ where f ( y, z ) yf ( y, z ), d1 ( y ) yd1 ( y ). Now, ~ ~ dy Q1 y max max f ( y, z ) 1 min d1 ( y) . dt y y, z y, z ~ ~ Let 1 max max f ( y, z ) 1 min d1 ( y) , y y, z y, z ~ ~ We assume that max f ( y, z) 1 min d1( y) or 1 0. y y, z Q Thus, we have y (t ) 1 y0 e1t , y0 0. 1 Q thus, y (t ) max 1 , y0 , 1 Q or lim sup y(t ) 1 , 1 0, y0 0. 1 t Similarly, if z 0 0 , third equation of the model gives, dz Q2 ( x) f ( y, z ) 2 d 2 ( z ), dt ~ dz Q2 ( K ) 2 z min d 2 ( z ), dt ~ where, d 2 ( z ) zd 2 ( z ) . ~ Now, if 2 2 min d 2 ( z ) 0, we have, z (t ) Q2 ( K ) 2 z0 e 2 t , 72 Q (K ) , z0 , this implies that z (t ) max 2 2 and hence, lim sup z (t ) t Q2 ( K ) 2 . This proves the boundedness of the system. 4.3 EQUILIBRIUM ANALYSIS Equilibrium points of the system are obtained by solving right hand side of equations given in (4.1.1). There are two possible equilibrium points of the system (4.1.1): Cancer free equilibrium point E (0, y, z ) and Interior Equilibrium point E ( x , y , z ) . Existence of E (0, y, z ) : In this case, the system is restricted to R yz . The equilibrium point E (0, y, z ) is obtained by solving following system of differential equations: dy Q1 f ( y, z ) 1d1 ( y ), dt (4.3.1) dz Q2 f ( y, z ) 2 d 2 ( z ), dt with y (t 0 ) y0 0, z (t0 ) z0 0 . Theorem 4.3.1: Let P1 max f ( y, z ) 0, (4.3.2) y, z 73 P2 min 1 min d1 ( y), 2 min d 2 ( z ) 0. y, z y z (4.3.3) Then, lim sup y (t ) z (t ) t Q1 Q2 (1 ) P1 . P2 Proof: Let us choose a function M (t ) y (t ) z (t ). (4.3.4) Differentiating (4.3.4) with respect to t, we have dM d ( y z ) Q1 Q2 f ( y, z ) f ( y, z ) 1d1 ( y ) 2 d 2 ( z ) dt dt ~ ~ Q1 Q2 (1 ) max f ( y, z ) 1 y min d1 ( y) 2 z min d 2 ( z ) y, z y z ~ ~ Q1 Q2 (1 ) P1 ( y z )1 min d1 ( y), 2 min d 2 ( z ) z y Q1 Q2 (1 ) P1 MP2 This implies that , Q Q2 (1 ) P1 lim sup M (t ) 1 , P2 t or Q Q2 (1 ) P1 lim sup y(t ) z (t ) 1 P2 t . Thus, we have shown that system (4.3.1) is dissipative under conditions (4.3.2) and (4.3.3). Lemma 4.3.1: Let us assume that ( y , z ) R yz such that Q1 1d1 ( y ) 1 Q2 2 d 2 ( z ) 0 as t . 74 Then the Equilibrium point E (0, y, z ) exists. Proof: Equating the right hand side of system (4.3.1) to zero we have, Q1 f ( y, z) 1d1( y) 0, (4.3.5) Q2 f ( y, z) 2d 2 ( z) 0. (4.3.6) We have shown that system (4.3.1) is dissipative under conditions (4.3.2) and (4.3.3) in theorem (4.3.1). Now from (4.3.5) and (4.3.6) we have, f ( y, z ) Q1 1d1 ( y ) iff 1d1 ( y ) Q1 1 iff Q1 1d1 ( y ) 1 Q2 2 d 2 ( z ), Q2 2 d 2 ( z ) 0, 1 (4.3.7) Q2 2 d 2 ( z ) 0 This proves the lemma. Existence of Interior Equilibrium point E ( x , y , z ) : E ( x , y , z ) is the equilibrium point of the system (4.1.1) if it satisfies its right hand side, that is B( x ) D( x ) h( x , y ) 0 (4.3.8) Q1 f ( y , z ) 1d1 ( y ) h( x , y ) 0 Q2 ( x ) f ( y , z ) 2 d 2 ( z ) (4.3.9) (4.3.10) within the region . We will prove the existence of E ( x , y , z ) by persistence analysis in section 4.4. 75 4.4 LOCAL STABILITY ANALYSIS We now discuss local stability of the system (4.1.1) about its equilibrium points. To do so we explore variational matrix due to linearization of (4.1.1) about equilibrium points and compute its eigenvalues. Negative eigenvalues of the variational matrix about an equilibrium point implies local asymptotic stability of that equilibrium point. General variational matrix of the system about an arbitrary equilibrium point is given by, B( x) D( x) hx ( x, y ) V (E) h x ( x, y ) ( x) f z ( y, z ) . f z ( y, z ) 2 d 2 ( z ) h y ( x, y ) f y ( y, z ) 1d1 ( y ) h y ( x, y ) 0 f y ( y, z ) 4.4.1 Local Stability of Cancer Free Equilibrium Point E (0, y, z ) : Using hypothesis H1-H6, the variational matrix of the system due to linearization of the system (4.4.1) about E (0, y, z ) is expressed as, B(0) D(0) hx (0, y ) V (E ) hx (0, y ) (0) f y ( y , z ) 1d1 ( y ) f z ( y, z ) . (4.4.1) f y ( y , z ) f z ( y , z ) 2 d 2 ( z ) 0 0 The eigenvalues of the variational matrix V (E ) are given by 1 B(0) D(0) hx (0, y ), (4.4.2) and the quadratic equation 2 f z ( y, z ) 1d1 ( y ) 2 d 2 ( z ) f y ( y, z ) f z ( y , z ) 2 d 2 ( z ) 1d1 ( y ) f y ( y , z ) f y ( y, z ) f z ( y , z ) 0 By the Routh Hurwitz criteria, the eigenvalues of variational matrix V (E ) have negative real parts if conditions, 76 f z ( y, z ) 1d1 ( y) 2d 2 ( z ) f y ( y, z ) 0, (4.4.3) f z ( y, z ) 2d2 ( z )1d1 ( y) f y ( y, z )f y ( y, z ) f z ( y, z ) 0 hold. (4.4.4) Thus, if conditions (4.4.2), (4.4.3) and (4.4.4) are satisfied then the equilibrium point E (0, y, z ) is locally asymptotically stable equilibrium point. Remark 1: We note that the equilibrium point E (0, y , z ) is a hyperbolic saddle point if 1 B(0) D(0) hx (0, y) 0 and 2 , 3 0 . In other words, we can say that E (0, y , z ) is repelling in x direction in this case. And E (0, y , z ) is hyperbolic source if 1 B(0) D(0) hx (0, y) 0 and 2 , 3 0 . Remark 2: Equilibrium point E (0, y , z ) demonstrate the scenario in which all the cancer cells are killed. In this case, immune system expel the cancer cells thoroughly out of the body. Let us now determine the existence of interior equilibrium point, Suppose equilibrium point E (0, y , z ) exists and is unique hyperbolic point repelling x direction. Further assume that neither periodic nor homoclinic orbits exist in the planes of R3 that is, T B(0) D(0) hx (0, y)dt 0 0 and system (4.1.1) is bounded then by the definition of uniform persistence given by Butler et al. (1986), Freedman and Rai (1995,1987), Nani and Freedman (2000), lim inf x(t ) 0, t lim inf y (t ) 0, t 77 lim inf z (t ) 0. t In particular, the system (4.1.1) exhibit uniform persistence and a positive interior equilibrium of the form E ( x , y , z ) exists. We now study the linearized stability of this equilibrium point. 4.4.2 Local Stability of Interior Equilibrium point E ( x , y , z ) : Using hypothesis H1-H6, the variational matrix of the system due to linearization of the system (4.1.1) about E ( x , y , z ) is expressed as B( x ) D( x ) hx ( x , y ) hy ( x , y ) 0 V (E ) hx ( x , y ) f y ( y , z ) 1d1 ( y ) f z ( y , z ) (4.4.5) ( x ) f y ( y , z ) f z ( y , z ) 2 d 2 ( z ) The eigenvalues of the variational matrix V ( E ) are given by the cubic equation 3 A12 A2 A3 0 (4.4.6) Where, A1 B( x ) D( x ) hx ( x , y ) f z ( y , z ) f y ( y , z ) hy ( x , y ) 1d1 ( y ) 2 d 2 ( z ) A2 f z ( y , z ) 1d1 ( y ) hy ( x , y ) 2 d 2 ( z ) f y ( y , z ) 1d1 ( y ) hy ( x , y ) B( x ) D( x ) f z ( y , z ) f y ( y , z ) 1d1 ( y ) 2 d 2 ( z ) hy ( x , y ) hx ( x , y ) f z ( y , z ) f y ( y , z ) 1d1 ( y ) 2 d 2 ( z ) h y ( x , y ) f y ( y , z ) f ( y , z ) d ( z ) z 2 2 d ( y ) A3 B( x ) D( x ) hx ( x , y ) 1 1 f ( y , z ) f ( y , z ) z y 78 hx ( x , y )hy ( x , y ) f z ( y , z ) 2 d 2 ( z ) ( x ) f z ( y , z )hy ( x , y ) By the Routh Hurwitz criteria, the eigenvalues of variational matrix V ( E ) have negative real parts if A1 0, A3 0 and A1 A2 A3 0. (4.4.7) Thus, if conditions given in (4.4.7) are satisfied then the interior equilibrium point E ( x , y , z ) is locally asymptotically stable equilibrium point. 4.5 GLOBAL STABILITY ANALYSIS In this section, we derive global stability of the equilibrium points by choosing the Lyapunov function and finding conditions for its derivative with respect to time to be negative definite. We use following two lemmas to prove global stability of the system used in by (Nani and Freedman, 2000). Lemma 4.5.1: Liapunov function V expressed as V X T AX where, x1 x 2 X . , X T x1 . x n x2 . . xn R n , and A be a symmetric n n matrix over R is negative definite if , 1. X T AX is negative definite, 2. X T AX is negative if A is negative definite, 3. A is negative definite if the eigenvalues of polynomial g (, A) A I n 0 has negative real parts. Frobenius in 1876 gave an alternative method to prove Lyapunov function V to be negative definite in the following lemma (Nani and Freedman, 2000): 79 Lemma 4.5.2: (Frobenius 1876) Let x1 x 2 X . , X T x1 . x n x2 . . xn R n , and let A be a symmetric n n matrix over R . Then the real quadratic form X T AX is negative definite if A is negative definite. In particular, a necessary and sufficient condition for the real symmetric matrix A to negative definite is that the principal minors of A starting with that of the first order be alternately negative and positive. 4.5.1 Global Stability of Cancer Free Equilibrium Point: Let us choose the Liapunov function 1 1 V x k1 ( y y ) 2 k 2 ( z z ) 2 2 2 (4.5.1) Derivative of V with respect to time t is given by dV dx dy dz k1 ( y y ) k 2 ( z z ) . dt dt dt dt (4.5.2) Using B( x) D( x) xg( x) , h( x, y) xh1 ( x, y), h1 ( x, y) yh2 ( x, y) Using system (4.1.1) in equation (4.5.2), we have dV xg ( x) yh2 ( x, y ) k1 ( y y )Q1 f ( y, z ) 1d1 ( y ) h( x, y ) dt k2 ( z z )Q2 ( x) f ( y, z) 2d 2 ( z), xg ( x) x yh2 ( x, y) yh2 ( x, y) xyh2 ( x, y) k1 ( y y) f ( y, z) f ( y, z ) 1k1( y y)d1( y) d1( y) xk1( y y) yh2 ( x, y) yh2 ( x, y) 80 xk1 ( y y) yh2 ( x, y) 2 k 2 ( z z )d 2 ( z) d 2 ( z ) k 2 ( z z ) f ( y, z) f ( y, z ) k2 ( z z ) ( x), writing (4.5.3) as (4.5.3) dV X T AX , dt (4.5.4) x where X y y , A is a real symmetric matrix defined as A aij , 1 i, j 3 z z with a11 1 A a12 2 1 a 2 13 1 a12 2 a22 1 a23 2 1 a13 2 1 a23 , 2 a33 and V a11x 2 a12 x( y y) a13 ( x x )( z z ) a22 ( y y) 2 a23 ( y y )( z z ) a33 ( z z ) 2 , where, a11 g ( x) yh2 ( x, y ) , x yh ( x, y) yh2 ( x, y ) k1 yh2 ( x, y), a12 2 yy k ( x) a13 2 , x k d ( y ) d1 ( y ) a22 1 1 1 , y y k f ( y, z ) f ( y , z ) k 2 f ( y, z ) f ( y , z ) a23 1 , zz yy 81 k d ( z) d 2 ( z ) a33 2 2 2 zz . Thus, by Frobenius theorem and hermiticity of matrix A , the matrix A and hence the quadratic form (4.5.3) is negative definite if the following criteria hold, A1 a11 0, A2 a11 1 a12 2 1 a12 2 a11 A3 det A 1 a12 2 1 a13 2 a 22 1 a 23 2 1 a12 2 0 and a 22 1 a13 2 1 a 23 0. 2 (4.5.5) a33 Thus, we have the following theorem for the global stability of cancer free equilibrium point: Theorem 4.5.1: The cancer free equilibrium point E (0, y, z ) is globally asymptotically stable if conditions (4.5.5) are satisfied. Remark: Global asymptotic stability of cancer free equilibrium E (0, y, z ) gives the criteria for total success of therapy in eliminating cancer cells from human body. In such cases immune system fights well with the cancer cells such that they are not able to proliferate and spread in the human body. 4.5.2 Global stability of Interior equilibrium point Let us consider a Lyapunov function V1 x x x ln x 1 1 l1 ( y y ) 2 l2 ( z z ) 2 . 2 x 2 Derivative of V1 with respect to time t is given by 82 (4.5.6) dV1 1 dx dy dz ( x x ) l1 ( y y ) l2 ( z z ) , dt x dt dt dt (4.5.7) Again using B( x) D( x) xg( x) , h( x, y) xh1 ( x, y), h1 ( x, y) yh2 ( x, y) Using system (4.1.1) in equation (4.5.7), we have dV1 ( x x ) xg( x) xh1( x, y) l1( y y )Q1 f ( y, z) 1d1( y) h( x, y) dt x l2 ( z z )Q2 ( x) f ( y, z ) 2 d 2 ( z ) , ( x x )g ( x) ( x x ) yh2 ( x, y) y h2 ( x, y ) ( x x ) y h2 ( x, y ) l1 ( y y ) f ( y, z ) f ( y , z ) l2 ( z z ) ( x) ( x ) 2l2 ( z z )d 2 ( z ) d 2 ( z ) (4.5.8) l2 ( z z ) f ( y, z ) f ( y , z ), 1l1 ( y y ) d1 ( y) d1 ( y ) l1 ( y y ) h( x, y) h( x , y ) writing (4.5.8) as dV1 X T BX , dt (4.5.9) x x where X y y , B is a real symmetric matrix defined as B bij , 1 i, j 3 z z with b11 1 B b12 2 1 b 2 13 and 1 b12 2 b22 1 b23 2 1 b13 2 1 b23 , 2 b33 dV1 b11 ( x x ) 2 b12 ( x x )( y y ) b13 ( x x )( z z ) b22 ( y y ) 2 dt 83 b23 ( y y )( z z ) b33 ( z z ) 2 . Here, b11 g ( x) y h2 ( x, y ) x x , yh2 ( x, y ) y h2 ( x, y ) h ( x, y ) h ( x , y ) , b12 l1 y y x x l ( x) ( x ) b13 2 , x x l d ( y ) d1 ( y ) b22 1 1 1 , y y l f ( y , z ) f ( y , z ) l 2 f ( y , z ) f ( y , z ) b23 1 , z z y y b33 2l2 d 2 ( z) d 2 ( z ) zz . Thus, by Frobenius theorem and hermiticity of matrix B , the matrix B and hence the quadratic form (4.5.9) is negative definite if the following criteria hold, B1 b11 0, B2 b11 B3 det B 1 b12 2 1 b13 2 b11 1 b12 2 1 b12 2 b22 1 b23 2 1 b12 2 0 and b22 1 b13 2 1 b23 0. 2 (4.5.10) b33 Thus, we have the following theorem for the global stability of interior equilibrium point: 84 Theorem 4.5.2: The interior equilibrium point E ( x , y , z ) is globally asymptotically stable if condition (4.5.10) are satisfied. Remark: Global stability of equilibrium point E ( x , y , z ) infers that cancer cells proliferate and attain a particular equilibrium level in the human body. In this case, although therapy is not able to eliminate cancer cells from the body yet it is effective in controlling the cancer cells and reducing them to a lowest possible limit. Thus, immunotherapy would be most effective in the case it is able to reduce the number of cancer cells in the body to lowest equilibrium value. 4.6 NUMERICAL SIMULATION Let us consider the following system to justify the analytical findings dx rx (1 x) a1 xy, dt dy Q1 b1 yz 1 y a2 xy, dt (4.6.1) dz Q2 x b2 yz 2 z , dt with, x(0) x0 0, y(0) y0 0, z (0) z0 0. Hence, B( x) D( x) rx (1 x), h( x, y) a1xy, f ( y, z) b1 yz, d1 ( y) y, d 2 ( z) z, ( x) x, a1 a2 , b1 b2 (4.6.2) We note that all the hypothesis H1-H6 hold for (4.6.2). Choosing the following values of the parameters in system (4.6.1): r 5, a1 0.5, b1 0.1, a2 0.2, b2 0.2, Q1 1, 85 Q2 2, 0.8, 1 0.2 and 2 0.1 (4.6.3) We find that all the equilibria of system (4.1.1) exist and are given by, E (0, 9.7562, 0.9750) and E* (0.0926, 9.0744, 1.0831) . The characteristic equation corresponding to E * is given by 3 2.48832 1.1484 0.1870 0. Roots of this equation are -1.9480, -0.2701+0.1517i, -0.2701-0.1517i. This implies that E * is a locally asymptotically stable equilibrium point owing to negative real parts of the eigenvalues of characteristic equation. Further, to show changes occurring in populations with time under different conditions, figures have been plotted between dependent variables and time for different parameter values. In Figs 1 and 2, global stability of the system is displayed by plotting the graphs in x y plane and x z plane respectively. It is observed from the figures that whatever initial value of equilibrium point is taken, trajectory always moves towards the equilibrium point. Thus, global stability of the system is ensured. Fig. 1, Graph of x versus y for different initial starts for the set of parameters same as (4.6.3) 86 Fig. 2, Graph of x versus z for different initial starts for the set of parameters same as (4.6.3) In Fig 3, variation of cancer cell population with time for different proliferation rate of hunting cells due to external infusion of immune cells is given. It is evident from the figure that cancer cell population decrease as proliferation rate of hunting cells, denoted by Q1 , increases and for a particular value of Q1 , cancer population vanish. It may be because lymphocytes are cytotoxic to cancer cells and increase in their proliferation causes reduction in number of cancer cells as enhanced population of lymphocytes kill more cancer cells. In this way, cancer cell population can be reduced largely and hence can be controlled. In Fig. 4, variation of cancer cell population with time for different recruitment rate of resting cells due to external infusion and different rate of induction of immune response in resting cells due to cancer antigens is determined. It is observed that cancer cell population decrease with increase in recruitment of resting cells during immunotherapy in the presence of antigenicity of cancer cells. However, if antigenicity is zero i.e., there is very little or no induction of immune response in 87 resting cells due to presence of cancer cells then cancer cell population rise to a large value. This implies that immunogenic cancers are easy to control to a lower level than non-immunogenic cancers. On the other hand, if rate of antigenicity is higher cancer cell population can be controlled. Fig. 3, Graph of Fig. 4, Graph of x versus t for different Q1 and other values of parameters are same as (4.6.3) x versus t for different Q2 and and other values of parameters are same as (4.6.3) 88 4.7 CONCLUSION This chapter considers a generalized mathematical model to discuss the effect of immune response to cancer cells using nonlinear differential equations. The model is analyzed using stability theory of differential equations and numerical simulation. It is found that model has two equilibrium points. Conditions for local and global stability of these equilibrium points are determined. Cancer free equilibrium point E (0, y, z ) gives the criteria for total success of therapy in eliminating cancer cells from human body. This case implies that immune system fights so well with the cancer cells that they are not able to proliferate and spread in the human body and hence cancer can be cured. Interior equilibrium point E ( x , y , z ) demonstrates the case of how the cancer cells proliferate and attain a particular equilibrium level in the human body. In this case, although therapy is not able to eliminate cancer cells from the body yet it is effective in controlling the cancer cells and reducing them to a lowest possible limit. To substantiate the analytical findings, the model is studied numerically for a particular case using fourth order Runge-Kutta method. Local stability conditions are verified for a set of hypothetical parameter values. Global stability of the interior equilibrium point is displayed graphically. Numerically, it is observed that cancer cell population is very sensitive to proliferation rate of hunting cells due to external infusion of immune cell during immunotherapy. A little increase in the numerical value of proliferation rate of lymphocytes produces a considerable decrease in the equilibrium level of cancer cell population. It is further observed that cancer cell population decrease with increase in induction of immune response in resting cells due to cancer antigens. However, if antigenicity is zero i.e., cancer is non89 immunogenic then cancer cell population rise to a large value. This implies that immunogenic cancers are easy to control to a lower level than non-immunogenic cancers. On the other hand, it is observed that if rate of antigenicity is higher cancer cell population can be controlled considerably to a lower level. 90
© Copyright 2026 Paperzz